Consider pharmacodynamic differences when prescribing angiotensin II receptor antagonists

被引：0
|
作者：
不详
机构：
来源：
SOUTH AFRICAN MEDICAL JOURNAL | 1998年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：C183 / C183
页数：1
相关论文
共 50 条
  • [41] Angiotensin II receptor antagonists and portal hypertension
    Lebrec, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (03): : 254 - 255
  • [42] Angiotensin II receptor antagonists: are they all the same?
    Mounier-Vehier, C
    Devos, P
    PRESSE MEDICALE, 2001, 30 (21): : 1072 - 1075
  • [43] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    NAKA, T
    KUBO, K
    FURUKAWA, Y
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (09) : 802 - 810
  • [44] DIHYDROPYRIMIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    ATWAL, KS
    AHMED, SZ
    BIRD, JE
    DELANEY, CL
    DICKINSON, KEJ
    FERRARA, FN
    HEDBERG, A
    MILLER, AV
    MORELAND, S
    OREILLY, BC
    SCHAEFFER, TR
    WALDRON, TL
    WELLER, HN
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (25) : 4751 - 4763
  • [45] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    STEINBERG, MI
    WIEST, SA
    PALKOWITZ, AD
    CARDIOVASCULAR DRUG REVIEWS, 1993, 11 (03): : 312 - 358
  • [46] Teratogenicity with angiotensin II receptor antagonists in pregnancy
    Boix, E
    Zapater, P
    Picó, A
    Moreno, O
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (11) : 1029 - 1031
  • [47] Teratogenicity with angiotensin II receptor antagonists in pregnancy
    E. Boix
    P. Zapater
    A. Picó
    O. Moreno
    Journal of Endocrinological Investigation, 2005, 28 : 1029 - 1031
  • [48] Renal effects of angiotensin II receptor antagonists
    Burgess, E
    BLOOD PRESSURE, 2001, 10 : 17 - 20
  • [49] Clinical implications of differences between angiotensin II antagonists
    Sever, PS
    Mancia, G
    AMERICAN JOURNAL OF MANAGED CARE, 1998, 4 (07): : S392 - S396
  • [50] What are the pharmacological differences between angiotensin II antagonists?
    Unger, T
    AMERICAN JOURNAL OF MANAGED CARE, 1998, 4 (07): : S388 - S391
12345